{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:30:20Z","timestamp":1793374220645,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:p>Disease-associated microglia (DAM) are a subset of microglia that appear at various stages of central nervous system neurodegenerative diseases. DAM were identified using single-cell RNA sequencing within Alzheimer\u2019s Disease (AD) where they were characterized by their unique localization near amyloid-\u03b2 plaques and their phagocytic and lipid-metabolizing features. Unfortunately, activation and etiology of DAM are only understood within the context of AD where Triggering Receptor Expressed On Myeloid Cells 2 (TREM2), a receptor for amyloid-\u03b2, appears to be the key regulator in microglial transition to a DAM state. Despite this reliance on TREM2 in AD, DAM appear across other neurodegenerative diseases in which TREM2 may not be a critical player. This begs the question of if DAM are truly the same across all neurodegenerative diseases or if there exists a heterogeneity to DAM across neurodegenerative pathologies. Investigation into this critical gap in the field regarding DAM etiology and activation, as well as DAM function, could be delineated utilizing models of Parkinson\u2019s disease (PD) to complement studies in models of AD. Though highly underexplored regarding DAM, PD with its pattern of protein aggregation-associated pathology like AD could serve as the spatiotemporal comparison against AD findings to ascertain the nature of DAM. The experimental vehicle that could guide the future of such investigation is the multi-omics model. With a compound approach focusing on exploring triggers for DAM at the chromatin or mRNA level and related protein output, it becomes possible to strongly characterize and firmly answer the question of what is a DAM.<\/jats:p>","DOI":"10.3389\/fncel.2024.1476461","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T04:31:43Z","timestamp":1730781103000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["The emerging role of disease-associated microglia in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Ritika R.","family":"Samant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Standaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.1227901","article-title":"Microglia: scapegoat, saboteur, or something else?","volume":"339","author":"Aguzzi","year":"2013","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/ana.26032","article-title":"Heritability enrichment implicates microglia in Parkinson's disease pathogenesis","volume":"89","author":"Andersen","year":"2021","journal-title":"Ann. Neurol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1074\/mcp.M200008-MCP200","article-title":"Discordant protein and mrna expression in lung adenocarcinomas","volume":"1","author":"Chen","year":"2002","journal-title":"Mol. Cell. Proteomics"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","article-title":"Trem2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11481-009-9164-4","article-title":"Heterogeneity of microglial activation in the innate immune response in the brain","volume":"4","author":"Colton","year":"2009","journal-title":"J. NeuroImmune Pharmacol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.immuni.2016.02.013","article-title":"Microglial physiology and pathophysiology: insights from genome-wide transcriptional profiling","volume":"44","author":"Crotti","year":"2016","journal-title":"Immunity"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","article-title":"Neuroinflammation: the devil is in the details","volume":"139","author":"Disabato","year":"2016","journal-title":"J. Neurochem."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/glia.24149","article-title":"Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding\/spreading mouse model of Parkinson's disease","volume":"70","author":"Garcia","year":"2022","journal-title":"Glia"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"12164","DOI":"10.1096\/fj.201900992R","article-title":"Trem2 deficiency aggravates alpha-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models","volume":"33","author":"Guo","year":"2019","journal-title":"FASEB J."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","article-title":"Disease progression-dependent effects of Trem2 deficiency in a mouse model of Alzheimer's disease","volume":"37","author":"Jay","year":"2017","journal-title":"J. Neurosci."},{"key":"ref12","first-page":"1003","article-title":"Neuroinflammation induces neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"J. Neurol. Neurosurg. Spine"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer's disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The Trem2-Apoe pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1073\/pnas.1520398113","article-title":"Purinergic receptor P2ry12-dependent microglial closure of the injured blood-brain barrier","volume":"113","author":"Lou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for Hla-Dr in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"Mcgeer","year":"1988","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3389\/fnins.2019.00916","article-title":"Role of the immune system in the development of the central nervous system","volume":"13","author":"Morimoto","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: a field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/1471-2164-9-246","article-title":"Correlation of mrna and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate","volume":"9","author":"Pascal","year":"2008","journal-title":"BMC Genomics"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1002\/ana.410440705","article-title":"Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration?","volume":"44","author":"Perl","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1172\/JCI77983","article-title":"Trem2 sustains microglial expansion during aging and response to demyelination","volume":"125","author":"Poliani","year":"2015","journal-title":"J. Clin. Invest."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-018-0254-8","article-title":"Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease","volume":"13","author":"Rangaraju","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1326-8-19","article-title":"Trem2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1093\/bioinformatics\/btn553","article-title":"Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models","volume":"24","author":"Rogers","year":"2008","journal-title":"Bioinformatics"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s004010050713","article-title":"Microglial activation in early stages of amyloid beta protein deposition","volume":"94","author":"Sasaki","year":"1997","journal-title":"Acta Neuropathol."},{"key":"ref27","first-page":"2022.10.12.511960","article-title":"Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease","author":"Schonhoff","year":"2022","journal-title":"bioRxiv"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-01099-x","article-title":"Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease","volume":"9","author":"Sobue","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41590-018-0212-1","article-title":"The identity and function of microglia in neurodegeneration","volume":"19","author":"Song","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018","volume-title":"Parkinson's disease: Pathogenesis and clinical aspects, Australia","author":"Stoker","year":"2018"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0301-0082(98)00069-0","article-title":"Reactive microgliosis","volume":"57","author":"Streit","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20041611","article-title":"Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2","volume":"201","author":"Takahashi","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/dneu.22864","article-title":"Microglial Trem2 in amyotrophic lateral sclerosis","volume":"82","author":"Xie","year":"2022","journal-title":"Dev. Neurobiol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2024.1476461\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T04:31:46Z","timestamp":1730781106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2024.1476461\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":34,"alternative-id":["10.3389\/fncel.2024.1476461"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2024.1476461","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"article-number":"1476461"}}